Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)

Gerald S. Falchook*, Georgina V. Long, Razelle Kurzrock, Kevin B. Kim, H. Tobias Arkenau, Michael P. Brown, Omid Hamid, Jeffrey R. Infante, Michael Millward, Anna Pavlick, Melvin T. Chin, Steven J. O'Day, Samuel C. Blackman, Curtis Martin, Peter Lebowitz, Bo Ma, Daniele Ouellet, Richard F. Kefford

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)'. Together they form a unique fingerprint.

Medicine & Life Sciences